Altered signaling lymphocytic activation molecule (SLAM) expression in HIV infection and redirection of HIV-specific responses via SLAM triggering

Clinical Immunology

Volumn 92, Issue 3, 1999, Pages 276-284

  Meroni, Luca ^a   Fusi, Maria Luisa ^a   Varchetta, Stefania ^a   Biasin, Mara ^a   Rusconi, Stefano ^a   Villa, Maria Luisa ^a   De Vries, Jan E ^b   Aversa, Gregorio ^b   Galli, Massimo ^a   Clerici, Mario ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b NOVARTIS RESEARCH INSTITUTE   (Austria)

Author keywords

Cytokines; HIV; Immunology; SLAM; T cell activation

Indexed keywords

CD150 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN; LYMPHOCYTE RECEPTOR; TETANUS TOXOID; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CELL SURFACE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

EID: 0032876960     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4747     Document Type: Article

References (30)

1. Gaines, H., von Sydow, M. A., von Stedingk, L. V., Biberfeld, G., Bottiger, B., Hansson, L. O., Lundbergh, P., Sonnerborg, A. B., Wasserman, J., Strannegaard, J., and Strannegaard, O. O., Immunological changes in primary HIV-1 infection. AIDS 4, 995-1001, 1995.
2. Pedersen, C., Dickmeiss, E., Gaub, J., Ryder, L. P., Platz, P., Lindhardt, B. O., and Lundgren, J. D., T-cell subset alterations and lymphocyte responsiveness to mitogens and antigen during severe primary infection with HIV: A case series of seven consecutive HIV seroconverters. AIDS 4, 523-529, 1990.
3. Daar, E. S., Moudgil, T., Meyer, R. D., and Ho, D. D., Transient high levels of viremia in patients with primary HIV-1 infection. N. Engl. J. Med. 324, 961-968, 1991.
4. Graziosi, C., Pantaleo, G., Butini, L., Demarest, J. F., Saag, M. G., Shaw, G. M., and Fauci, A. S., Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc. Natl. Acad. Sci. USA 90, 6405-6410, 1993.
5. + T lymphocyte activity associated with control of viremia in primary HIV type-1 infection. J. Virol. 68, 6103-6110, 1994.
6. Koup, R. A., and Ho, D. D., Shutting down HIV. Nature 370, 416, 1994.
7. Meroni, L., Trabattoni, D., Balotta, C., Riva, C., Gori, A., Moroni, M., Villa, M. L., Clerici, M., and Galli, M., Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection. AIDS 10, 23-30, 1996.
8. Musey, L., Hughes, J., Schacker, T., Shea, T., Corey, L., and McElrath, M. J., Cytotoxic T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N. Engl. J. Med. 337, 1267-1272, 1996.
9. Legac, E., Autran, B., Merle-Beral, H., Katlama, C., and Debrè, P., CD4+CD7 - CD57+ T cells: A new T lymphocyte subset expanded during HIV infection. Blood 79, 1746-1752, 1992.
10. Autran, B., Legac, E., Blanc, C., and Debrè, P., A Th0/Th2-like function of CD4+CD7+ T helper cells from normal donors and HIV infected patients. J. Immunol. 154, 1408-1414, 1995.
11. Cocks, B. G., Chang, C. C., Carballido, J. M., Yssel, H., de Vries, J. E., and Aversa, G., A novel receptor involved in T-cell activation. Nature 376, 260-264, 1995.
12. Aversa, G., Carballido, J., Punnonen, J., Chang, C. C., Hauser, T., Cocks, B. G., and de Vries, J. E., SLAM and its role in T cell activation and Th cell responses. Immunol. Cell. Biol. 75, 202-230, 1997.
13. Sayos, J., Wu, C., Morra, M., Wang, N., Zhang, X., Allen, D., van Schaik, S., Notarangelo, L., Geha, R., Roncarolo, M. G., Oettgen, H., De Vries, J. E., Aversa, G., and Terhost, C., SAP, the protein encoded by the X-linked lymphoproliferative disease gene regulates signal transduction events induced through the co-receptor molecule SLAM. Nature 395, 462-466, 1998.
14. Isomak, P., Aversa, G., Cocks, B. G., Luukkainen, R., Saario, R., Toivanen, P., de Vries, J. E., and Punnonen, J., Expression of signaling lymphocytic activation molecule in vivo. J. Allergy Clin. Immunol. 103, 114-121, 1998.
15. Ferrante, P., Fusi, M. L., Saresella, M., Caputo, D., Biasin, M., Trabattoni, D., Salvaggio, A., Clerici, E., de Vries, J. E., Aversa, G., Cazzullo, C. L., and Clerici, M., Cytokine production and surface markers expression in acute and stable multiple sclerosis. Dysregulated IL-12 production and augmented SLAM-expressing lymphocytes in acute multiple sclerosis. J. Immunol. 160, 1514-1522, 1998.
16. Urdea, M. S., Wilber, J. C., Yeghiazaran, T., Todd, J. A., Kern, D. G., Fong, S. J., Besemer, D., Hoo, B., Sheridan, P. J., Kokka, R., Neuwald, P., and Pachl, C. A., Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay. AIDS 7, S1-S8, 1993.
17. Clerici, M., Stocks, N. I., Zajac, R. A., Boswell, R. N., Bernstein, D. C., Mann, D. L., Shearer, G. M., and Berzofsky, J. A., IL-2 production permits detection of antigenic peptide recognition by T helper lymphocytes from asymptomatic, HIV seropositive individuals. Nature 339, 383-386, 1989.
18. Aversa, G., Chang, C. C., Carbadillo, J. M., Cocks, B. G., and de Vries, J. E., Engagement of the signalling activation molecule (SLAM) on activated T cells results in IL-2 independent cyclosporin A-sensitive T cell proliferation and IFNγ production. J. Immunol. 158, 4036-4042, 1997.
19. Carballido, J. M., Aversa, G., Kaltoft, K., Cocks, B. G., Punnonen, J., Yssel, H., Thesdrup-Pedersen, K., and de Vries, J. E., Reversal of human allergic T helper 2 responses by engagement of signalling lymphocytic activation molecule. J. Immunol. 159, 4316-4322, 1997.
20. List, A. F., Greco, F. A., and Vogler, L. B., Lymphoproliferative diseases in immunocompromised hosts: The role of Epstein-Barr virus. J. Clin. Oncol. 5, 1673-1679, 1987.
21. Levy, J. A., Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57, 83-154, 1993.
22. Fauci, A. S., Host factors and the pathogenesis of HIV-induced disease. Nature 384, 529-535, 1996.
23. Shearer, G. M., HIV-induced immunopathogenesis. Immunity 9, 587-595, 1998.
24. Clerici, M., Stocks, N. I., Zajac, R. A., Boswell, R. N., Lucey, D. R., Via, C. S., and Shearer, G. M., Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J. Clin. Invest. 84, 1892-1899, 1989.
25. Meyaard, L., Hovenkamp, E., Keet, I. P., Hooibrink, B., de Jong, I. H., Otto, S. A., and Miedema, F., Single cell analysis of IL-4 and IFNγ production from T cells of HIV-infected individuals: Decreased IFNγ in the presence of preserved IL-4 production. J. Immunol. 157, 2712-2720, 1996.
26. Ullum, H., Cozzi Lepri, A., Bendtzen, K., Victor, J., Gotzsche, P. C., Phillips, A. N., Skinhoj, P., Klarlund, P., and Pedersen, B., Low production of interferon gamma is related to disease progression in HIV infection: Evidence from a cohort of 347 HIV-infected individuals. AIDS Res. Hum. Retrovir. 13, 1039-1045, 1997.
27. Than, S., Hu, R., Oyazu, N., Romano, J., Wang, X., Sheikh, S., and Pahwa, S., Cytokine pattern in relation to disease progression in HIV-infected children. J. Infect. Dis. 175, 47-55, 1997.
28. de Vries, J. E., and de Waal Malefyt, R., Interleukin-10. Immunol. Rev. 97, 121-146, 1998.
29. Clerici, M., Balotta, C., Meroni, L., Ferrario, E., Riva, C., Trabattoni, D., Ridolfo, A. L., Villa, M. L., Shearer, G. M., Moroni, M., and Galli, M., Type 1 cytokine production and low prevalence of viral isolation correlate with long term non progression in HIV infection. AIDS Res. Hum. Retrovir. 12, 1053-1059, 1996.
30. Rosenberg, E. S., Billingsley, J. M., Caliendo, A. M., Boswell, S. L., Sax, P. E., Klams, S. A., and Walker, B. D., Vigorous HIV-1-specific CD4+ T cell responses associates with control of viremia. Science 278, 1447-1451, 1997.